Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)

NCT02832128 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Hearing Loss
Hearing Impairment

Interventions

DRUG: AUT00063
DRUG: Placebo

Sponsor

Autifony Therapeutics Limited